US to target TV drug ads

Advertising and pharmaceutical industry experts say an executive order Trump signed last week could threaten the business of both drugmakers and their media companies, which raked in an estimated $5billion in ad revenue from Big Pharma in 2024. The order instructs the Department of Health and Human Services to ensure “transparency and accuracy”.